video
Anand Kumthekar, MD, of the Albert Einstein College of Medicine, believes it's an exciting time for the treatment of PsA, with much work yet to be done. "We have excellent agents for psoriasis, we have good agents for psoriatic arthritis," he states. (1:30)
To what extent do patients with psoriatic arthritis take multiple medications to treat their arthritis and other conditions? And how does this compare to people without PsA in the general population? These questions were at the center of a study that produced several interesting findings.
A new study from Weill Cornell Medicine found that patients with isolated nail psoriasis had nail findings for almost 3 years before they were diagnosed with psoriatic arthritis. It may be possible to reduce disease burden and prevent progression to PsA if these clues are detected earlier.
The U.S. UPLIFT trial assessed patient and physician perceptions about psoriatic disease. About half of psoriasis patients felt that their treatment goals were aligned with their dermatologists'; less than 10% of psoriatic arthritis patients felt the same.
video
Anand Kumthekar, MD, of the Albert Einstein College of Medicine, discusses the key takeaways from GRAPPA's 2022 updated treatment recommendations. (2:27)
Norwegian investigators have concluded that active inflammatory disease—specifically in the form of axial spondyloarthritis and psoriatic arthritis—is an important risk factor for both elective and emergency cesarean section.
Researchers have found that caring for a dog may improve overall QoL in patients with inflammatory arthritis. Cats, not so much.
According to a new study from Japan, psoriatic arthritis, but not psoriasis vulgaris, was more common among patients with psoriasis who had a family history of psoriasis.
These researchers assessed the contribution of pain in the relationship between PsA and depression/anxiety. PsA hurts in more ways than one.
In a study from Israel, men with psoriatic arthritis (PsA) had a higher prevalence of enthesitis on ultrasound compared with female PsA patients, despite having lower levels of reported clinical disease activity.